Get it on Google Play

Aelis Farma's Down syndrome trial clears safety review

July 16, 2026 1:01 AM EDT Send to a Friend
Aelis Farma (Euronext Paris: AELIS), a clinical-stage biopharmaceutical company, announced that an Independent Data Monitoring Committee (IDMC) has recommended the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login